Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rena Yadlapati

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
The New England Journal of Medicine|January 16, 2020
Medical versus Surgical Treatment for Refractory HeartburnRena Yadlapati, John E Pandolfino
Digestive Diseases and Sciences|November 20, 2013
Disparities in endoscopy use for colorectal cancer screening in the United StatesAndrew J Gawron, Rena Yadlapati
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2019
Laryngopharyngeal Reflux Is an Eternally Rolling BoulderRena Yadlapati, David A Katzka
Foregut (Thousand Oaks, Calif.)|January 26, 2022
How Updates in Chicago Classification Impact Clinical PracticeRena Yadlapati, Peter J Kahrilas
BMC Medicine|February 22, 2017
When is proton pump inhibitor use appropriate?Rena Yadlapati, Peter J Kahrilas
Neurogastroenterology and Motility|January 23, 2023
Chagas' disease achalasia may represent a sub-group of type 2 achalasia without focal elevated pressuresEric E Low, Rena Yadlapati
Alimentary Pharmacology & Therapeutics|January 9, 2024
Review article: Diagnosis and management of laryngopharyngeal refluxAmanda J Krause, Rena Yadlapati
The Lancet. Gastroenterology & Hepatology|October 9, 2020
A multidisciplinary personalised paradigm for achalasiaEric E Low, Rena Yadlapati
The Journal of Allergy and Clinical Immunology|July 22, 2017
The "dangers" of chronic proton pump inhibitor useRena Yadlapati, Peter J Kahrilas
Gastroenterology|October 11, 2024
The First Approved Therapy in Infants and Young Children With Eosinophilic Esophagitis - Now the Big Question: Where Will Dupilumab Fit Into Real-World Practice?Eric E Low, Rena Yadlapati
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
The New England Journal of Medicine|January 16, 2020
Medical versus Surgical Treatment for Refractory HeartburnRena Yadlapati, John E Pandolfino
Digestive Diseases and Sciences|November 20, 2013
Disparities in endoscopy use for colorectal cancer screening in the United StatesAndrew J Gawron, Rena Yadlapati
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2019
Laryngopharyngeal Reflux Is an Eternally Rolling BoulderRena Yadlapati, David A Katzka
Foregut (Thousand Oaks, Calif.)|January 26, 2022
How Updates in Chicago Classification Impact Clinical PracticeRena Yadlapati, Peter J Kahrilas
BMC Medicine|February 22, 2017
When is proton pump inhibitor use appropriate?Rena Yadlapati, Peter J Kahrilas
Neurogastroenterology and Motility|January 23, 2023
Chagas' disease achalasia may represent a sub-group of type 2 achalasia without focal elevated pressuresEric E Low, Rena Yadlapati
Alimentary Pharmacology & Therapeutics|January 9, 2024
Review article: Diagnosis and management of laryngopharyngeal refluxAmanda J Krause, Rena Yadlapati
The Lancet. Gastroenterology & Hepatology|October 9, 2020
A multidisciplinary personalised paradigm for achalasiaEric E Low, Rena Yadlapati
The Journal of Allergy and Clinical Immunology|July 22, 2017
The "dangers" of chronic proton pump inhibitor useRena Yadlapati, Peter J Kahrilas
Gastroenterology|October 11, 2024
The First Approved Therapy in Infants and Young Children With Eosinophilic Esophagitis - Now the Big Question: Where Will Dupilumab Fit Into Real-World Practice?Eric E Low, Rena Yadlapati
Pageof 20